Papers

13

Total Citations

396

H-Index

8

About

Paul Van Schil is a leading thoracic surgeon whose career has been defined by pioneering advances in the surgical management of thymic epithelial tumors and the integration of robotic technology into thoracic oncology. His foundational work on thymoma, particularly the highly cited 2009 review "Thymoma: A Focus on Current Therapeutic Management" (196 citations), established key principles for staging and surgical treatment of these rare mediastinal neoplasms. Van Schil has been at the forefront of minimally invasive surgery, conducting prospective studies comparing quality of life after open versus robotic-assisted thoracoscopic resection for anterior mediastinal masses, demonstrating the patient-centered benefits of robotic approaches. His expertise extends to lung cancer screening, where he contributed to a clinical statement on the surgeon's role in CT screening programs, and to complex robotic procedures such as mediastinal parathyroidectomy and fluorescence-guided thoracic duct dissection during esophagectomy. With recent reviews on robotic surgery in non-small cell lung cancer and thymic epithelial tumors, Van Schil continues to shape the evidence base for minimally invasive thoracic surgery, cementing his reputation as a key figure in the field's technological evolution.

Research Focus

Key Achievements

8
H-Index
13
Papers
396
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Thymoma: A Focus on Current Therapeutic Management
196 citations · 2009
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 54
🏛 Institutions: Antwerp University Hospital, Dow Chemical (Belgium), University of Antwerp

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago